AI assistant
PFIZER INC — Director's Dealing 2015
Jun 2, 2015
29831_dirs_2015-06-02_6b1d6f1e-6dae-4942-aa83-0d9f769bfa83.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2015-05-29
Reporting Person: HILL CHARLES H (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-29 | Common Stock | S | 42870.0000 | $34.9200 | Disposed | 69357.0000 | Direct |
| 2015-05-29 | Common Stock | I | 7489.0000 | $34.7500 | Acquired | 8173.0000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-29 | Phantom Stock Units SSP | $ | I | 33278.0000 | Acquired | Common Stock (33278.0000) | Direct |
Footnotes
F1: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan.
F2: Each unit represents one phantom share of common stock.
F3: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
F4: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.